SA
Therapeutic Areas
Sama Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| iMAGiNE™ Platform for Clinical Trial Acceleration | Cognitive, Affective, Interoceptive, Substance Use Disorders | Development |
| iMAGiNE™ Platform for Clinical Decision Support | Major Depressive Disorder, ADHD, PTSD, OCD, Schizophrenia | Development |
| iMAGiNE™ for Direct-to-Consumer Brain Health Tracking | Wellness, Longevity, Psychedelic Medicine Integration | Development |
Leadership Team at Sama Therapeutics
FH
Franz Hell, PhD
Chief AI Officer, Co-Founder
AT
Adam Teed, PhD
Chief Operating Officer, Co-Founder
AA
Aurina Arnatkeviciute, PhD
Chief Data Scientist, Co-Founder
AT
Alan Tucholka, PhD
Chief Technology Officer
PS
Priyal Sheth, MSc
Chief Business Officer
RH
Russell Hanson, PhD
Chief Innovation Officer
EM
Elias Mouchlianitis, PhD
Chief Scientific Officer